Surgical Director, Living Donor Kidney Transplant Program
Professor of Clinical Surgery
To see if Junichiro Sageshima is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Cypress Building, Transplant Surgery
2221 Stockton Blvd.
Sacramento, CA 95817
Phone: 916-734-2111
My goal is to deliver person-centered, equitable care effectively and efficiently. As a transplant surgeon, I aim to provide more opportunities and better outcomes for patients with end-stage organ disease by optimizing organ selection, recovery, preservation, transplantation, and patient management.
I believe that "transplantation" requires multidisciplinary teamwork and that patients and their families are crucial transplant team members.
Dr. Sageshima is a fellowship-trained transplant surgeon offering care for patients with end-stage organ disease. Sageshima has special clinical interest and expertise in adult and pediatric kidney transplantation, pancreas transplantation, living donor surgery, organ recovery/preservation, and vascular/peritoneal dialysis access surgery.
Dr. Sageshima's research focuses on improving healthcare outcomes; he collaborates with diverse stakeholders to maximize population health and optimize healthcare delivery in patients with end-stage organ disease. Sageshima utilizes multimodal data analyses of organs, donors, and recipients by machine learning and artificial intelligence. Sageshima assesses the impact of new science and technology, such as transplant tolerance, minimally invasive and robotic-assisted surgery.
Transplant Surgery
M.D., Showa University School of Medicine, Shinagawa, Tokyo, Japan 1990
Surgery, Tokyo Women's Medical College Hospital, Tokyo, Japan 1992-1996
Transplant Surgery, University of Miami/Jackson Memorial Hospital, Miami FL 2002-2004
“Diamond Doc Award” Extraordinary Patient Care, UC Davis Medical Center, 2021
Sageshima J, Chandar J, Chen LJ, Shah R, Al Nuss A, Vincenzi P, Morsi M, Figueiro J, Vianna R, Ciancio G, Burke GW 3rd. How to Deal With Kidney Retransplantation-Second, Third, Fourth, and Beyond. Transplantation. 2022 Apr 1;106(4):709-721. doi:10.1097/TP.0000000000003888. PMID:34310100.
Sageshima J, Troppmann C, McVicar JP, Santhanakrishnan C, de Mattos AM, Perez RV. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients. Transplantation. 2018 Jul;102(7):1179-1187. doi:10.1097/TP.0000000000002096. PMID:29953423.
Paloyo S, Sageshima J, Gaynor JJ, Chen L, Ciancio G, Burke GW. Negative impact of prolonged cold storage time before machine perfusion preservation in donation after circulatory death kidney transplantation. Transpl Int. 2016 Oct;29(10):1117-25. doi:10.1111/tri.12818. Epub 2016 Aug 12. PMID:27421771.
Sageshima J, Ciancio G, Chen L, Dohi T, El-Hinnawi A, Paloyo S, Misawa R, Ekwenna O, Yatawatta A, Burke GW 3rd. Everolimus with low-dose tacrolimus in simultaneous pancreas and kidney transplantation. Clin Transplant. 2014 Jul;28(7):797-801. doi:10.1111/ctr.12381. Epub 2014 Jun 1. PMID:24779669.
Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW 3rd, Mundel P. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013 Dec 19;369(25):2416-23. doi:10.1056/NEJMoa1304572. Epub 2013 Nov 8. PMID:24206430.
Ciancio G, Sageshima J, Akpinar E, Gaynor JJ, Chen L, Zarak A, Hanson L, Tueros L, Guerra G, Mattiazzi A, Kupin W, Roth D, Ricordi C, Burke GW 3rd. A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. Transplantation. 2013 Nov 15;96(9):800-6. doi:10.1097/TP.0b013e3182a0f68c. PMID:23903014.
Ciancio G, Sageshima J, Chen L, Gaynor JJ, Hanson L, Tueros L, Montenora-Velarde E, Gomez C, Kupin W, Guerra G, Mattiazzi A, Fornoni A, Pugliese A, Roth D, Wolf M, Burke GW 3rd. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. Am J Transplant. 2012 Dec;12(12):3363-76. doi:10.1111/j.1600-6143.2012.04235.x. Epub 2012 Sep 4. PMID:22946986.
Hibi T, Sageshima J, Molina E, Ciancio G, Nishida S, Chen L, Arosemena L, Mattiazzi A, Guerra G, Kupin W, Tekin A, Selvaggi G, Levi D, Ruiz P, Livingstone AS, Roth D, Martin P, Tzakis A, Burke GW. Predisposing factors of diminished survival in simultaneous liver/kidney transplantation. Am J Transplant. 2012 Nov;12(11):2966-73. doi:10.1111/j.1600-6143.2012.04121.x. Epub 2012 Jun 8. PMID:22681708.
Ciancio G, Gaynor JJ, Sageshima J, Roth D, Kupin W, Guerra G, Tueros L, Zarak A, Hanson L, Ganz S, Chen L, Ruiz P, Livingstone AS, Burke GW 3rd. Machine perfusion following static cold storage preservation in kidney transplantation: donor-matched pair analysis of the prognostic impact of longer pump time. Transpl Int. 2012 Jan;25(1):34-40. doi:10.1111/j.1432-2277.2011.01364.x. Epub 2011 Oct 8. PMID:21981661.
Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011 Jul 31;17(8):952-60. doi:10.1038/nm.2411. PMID:21804539.